早期深镇静与COVID-19疫情期间机械通气患者临床结局的双中心队列研究:COVID-SED研究
这项双中心回顾性队列研究纳入2020年3月至8月连续收治的391例机械通气成人,收集前48小时镇静相关数据,深镇静定义为RASS -3至-5或Riker SAS 1-3。283例(72.4%)发生早期深镇静,与浅镇静相比,深镇静患者芬太尼、丙泊酚、咪唑仑和氯胺酮累积剂量更高,无呼吸机、无ICU和无住院天数更少,死亡率更高(30.4% vs 11.1%,p<0.01)。校正混杂因素后,早期深镇静仍与更高死亡率显著相关(调整OR 3.44;95%CI 1.65-7.17;p<0.01),在COVID-19亚组中结果稳定。作者认为应继续以方案驱动、尽早以浅镇静为目标作为默认策略。
要点
- 391例机械通气成人中283例(72.4%)出现早期深镇静,提示疫情期间ICU早期深镇静普遍。
- 深镇静组死亡率30.4%,浅镇静组11.1%(p<0.01);校正混杂后早期深镇静与住院死亡率独立相关(调整OR 3.44;95%CI 1.65-7.17;p<0.01)。
- 与浅镇静相比,深镇静患者芬太尼、丙泊酚、咪唑仑和氯胺酮累积剂量更高,无呼吸机、无ICU和无住院天数更少(p<0.01)。
- 在COVID-19患者亚组中,早期深镇静与更差结局的关联结果稳定。
- 作者认为应继续以方案驱动、尽早以浅镇静为目标作为机械通气患者镇静的默认策略。
适用人群与场景
- 2020年3月至8月双中心连续收治的机械通气成人患者。
- 研究场景为急诊科(ED)和重症监护室(ICU),收集插管后前48小时镇静相关数据。
诊断标准与关键阈值
- 深镇静定义:Richmond Agitation-Sedation Scale(RASS)-3至-5分,或Riker Sedation-Agitation Scale(SAS)1-3分。
- 浅镇静:未达到上述深镇静标准的镇静深度。
研究设计与关键结果
- 研究类型:双中心、回顾性队列研究,研究周期6个月(2020年3月至8月),纳入391例连续机械通气成人。
- 主要结局:住院死亡率。深镇静组30.4% vs 浅镇静组11.1%(p<0.01);校正混杂因素后早期深镇静与更高死亡率独立相关(调整OR 3.44;95%CI 1.65-7.17;p<0.01)。
- 深镇静发生率为72.4%(283/391)。
- 与浅镇静相比,深镇静患者芬太尼、丙泊酚、咪唑仑和氯胺酮累积剂量更高。
- 次要结局:深镇静患者无呼吸机天数、无ICU天数和无住院天数均少于浅镇静患者(p<0.01)。
- 亚组分析:在COVID-19患者亚组中,早期深镇静与更差结局的关联结果稳定。
证据类型、等级与局限
- 证据类型:双中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,应继续以方案驱动的镇静管理、尽早以浅镇静为目标作为机械通气患者的默认策略。
- 疫情期间ICU机械通气患者早期深镇静常见,且与更差临床结局独立相关,提示临床应关注前48小时镇静深度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mechanically ventilated patients have experienced greater periods of prolonged deep sedation during the coronavirus disease (COVID-19) pandemic. Multiple studies from the pre-COVID era demonstrate that early deep sedation is associated with worse outcome. Despite this, there is a lack of data on sedation depth and its impact on outcome for mechanically ventilated patients during the COVID-19 pandemic. We sought to characterize the emergency department (ED) and intensive care unit (ICU) sedation practices during the COVID-19 pandemic, and to determine if early deep sedation was associated with worse clinical outcomes.
STUDY DESIGN AND METHODS: Dual-center, retrospective cohort study conducted over 6 months (March-August, 2020), involving consecutive, mechanically ventilated adults. All sedation-related data during the first 48 h were collected. Deep sedation was defined as Richmond Agitation-Sedation Scale of - 3 to - 5 or Riker Sedation-Agitation Scale of 1-3. To examine impact of early sedation depth on hospital mortality (primary outcome), we used a multivariable logistic regression model. Secondary outcomes included ventilator-, ICU-, and hospital-free days.
RESULTS: 391 patients were studied, and 283 (72.4%) experienced early deep sedation. Deeply sedated patients received higher cumulative doses of fentanyl, propofol, midazolam, and ketamine when compared to light sedation. Deep sedation patients experienced fewer ventilator-, ICU-, and hospital-free days, and greater mortality (30.4% versus 11.1%) when compared to light sedation (p < 0.01 for all). After adjusting for confounders, early deep sedation remained significantly associated with higher mortality (adjusted OR 3.44; 95% CI 1.65-7.17; p < 0.01). These results were stable in the subgroup of patients with COVID-19.
CONCLUSIONS: The management of sedation for mechanically ventilated patients in the ICU has changed during the COVID pandemic. Early deep sedation is common and independently associated with worse clinical outcomes. A protocol-driven approach to sedation, targeting light sedation as early as possible, should continue to remain the default approach.
参考来源
- Stephens RJ, Evans EM, Pajor MJ, et al. A dual-center cohort study on the association between early deep sedation and clinical outcomes in mechanically ventilated patients during the COVID-19 pandemic: The COVID-SED study. Crit Care. 2022. PMID: 35705989. doi:10.1186/s13054-022-04042-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。